Featured Story Conformal Medical Raises $35 Million in Oversubscribed Series D Round June 6, 2023-Conformal
Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO May 15, 2023-Sera Prognostics
Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO May 15, 2023-Sera Prognostics
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL February 15, 2023-Sera Prognostics
Conformal Medical Announces Positive One-Year Data from its Left Atrial Appendage Closure Performed Under Conscious Sedation Study February 3, 2023-Conformal
JSCAI Publishes Peer-Reviewed Article Highlighting Effective Performance of Conformal Medical’s Left Atrial Appendage (CLAAS®) Device January 8, 2023-Conformal
Sera Prognostics Announces Publication of Data Predicting Clinical Utility and Cost Effectiveness of the PRETRM® Test-and-Treat Strategy Across Diverse Populations November 15, 2022-Sera Prognostics
Banner Health, Sera Prognosics Team Up to Provide PreTRM® Test to Cover Pregnant Members September 22, 2022-Sera Prognostics
